Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
This therapy uses a specialized gel activated by LED light to deliver fluorescent energy deep into the skin and tissues, stimulating the bodys natural healing response
10.1146/annurev-pathol-012513-104649 166 OktayK
Complete Peptide Half-Life Chart The table below summarizes plasma half-life, lyophilized storage temperature, reconstituted stability at 28 C, and typical research dose ranges reported in the peer-reviewed literature and in pharmacokinetic modeling studies